CXCR4 and idiopathic pulmonary fibrosis: Patients with high pulmonary CXCR4 signals on follow-up PET scans after 6 weeks into treatment have a statistically worse outcome at 12 months [314], predicting IPF patient outcomes with pirfenidone.